September 13, 2017 TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM / PEA‐PME eligible), a medical device company specializing in the minimally invasive treatment of vertebral fractures, will announce its 3rd quarter 2017 sales on Wednesday, 25 October, 2017. The other dates announced on the original schedule remain unchanged: Announcement […]